Validation of the Decipher prostate cancer classifier in intermediate to high-risk men treated with radical prostatectomy but without additional therapy upon PSA rise.

作者
Ashley Evan Ross,Kasra Yousefi,Bruce J. Trock,Voleak Choeurng,Lucia L.C. Lam,Helen L. Fedor,Mercedeh Ghadessi,Christine Buerki,Stephanie A. Glavaris,Debasish Sundi,Jeffrey J. Tosoian,Misop Han,Elizabeth B. Humphreys,Alan Wayne Partin,George Jabboure Netto,Elai Davicioni,Edward Matthew Schaeffer
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:33 (7_suppl): 173-173
标识
DOI:10.1200/jco.2015.33.7_suppl.173
摘要

173 Background: Radical prostatectomy (RP) is a primary treatment option for men with intermediate and high risk prostate cancer. Though many will be effectively cured with local therapy alone, these men are by definition at higher risk of adverse pathologic findings and clinical disease recurrence. The Decipher test has been previously shown to predict metastatic progression in cohorts that included adjuvant and salvage therapy after RP. Here we evaluate Decipher in a natural history cohort of at risk men who received no additional treatment until the time of metastatic progression. Methods: Men with NCCN intermediate or high risk localized prostate cancer treated with RP at the Johns Hopkins Medical Institute (1992-2010) with at least 5 years of post-operative follow up were identified. Only men with initial undetectable PSA after surgery and who received no therapy prior to metastasis detection were included (n=765). A case-cohort design was used to randomly sample the cohort. The highest Gleason grade cancer tissue was used for RNA extraction and Decipher genomic classifier (GC) scores were calculated with a locked 22-biomarker signature and algorithm. Results: GC results were obtained for 260 patients, 28% had positive margins, 77% had EPE, 28% had SVI, 20% had lymph node invasion and 36% had Gleason ≥8 disease. Median follow up was 9 (IQR 6-12) years and at 15 years post RP the cumulative incidence of BCR, metastasis and prostate cancer specific death was 38%, 21% and 9%. Median GC score was 0.34 (IQR: 0.22-0.52) and was significantly higher among men experiencing metastatic progression during follow up (0.47 vs 0.28 respectively p<0.001). In UVA and MVA (adjusting for clinical covariates), GC had an HR of 1.48 (95% CI: 1.30-1.69, p<0.001) and 1.37 (95% CI: 1.21-1.55, p<0.001) per 10% increase, respectively. Conclusions: The majority of the men in this study had excellent long-term outcomes with surgery alone. Elevated Decipher scores correlated with metastatic events, independent of clinical risk factors. Use of Decipher may allow for selection of candidates for immediate vs. delayed adjuvant or salvage therapy following prostatectomy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Rongxing完成签到 ,获得积分10
刚刚
刚刚
1秒前
小蘑菇的应助被xucc采纳,获得10
1秒前
理想完成签到,获得积分10
2秒前
2秒前
2秒前
3秒前
GamAooL发布了新的文献求助10
4秒前
4秒前
啦啦啦完成签到 ,获得积分10
5秒前
Iriss完成签到 ,获得积分10
5秒前
5秒前
行走的荷尔蒙的应助被依山尽采纳,获得30
6秒前
ZYP完成签到,获得积分10
6秒前
科目三的应助被小棕瓶采纳,获得10
6秒前
revo完成签到,获得积分10
7秒前
温暖大米完成签到,获得积分20
7秒前
酷炫的金鱼完成签到 ,获得积分10
7秒前
喜悦的聪展完成签到 ,获得积分10
7秒前
典雅碧空发布了新的文献求助10
8秒前
慕青的应助被Lily采纳,获得10
8秒前
天真的乌龟完成签到 ,获得积分10
8秒前
12发布了新的文献求助10
9秒前
syvshc的应助被chenlina采纳,获得10
9秒前
9秒前
9秒前
美丽冬卉发布了新的文献求助10
9秒前
DW的应助被雪白玉米采纳,获得10
10秒前
lm发布了新的文献求助10
10秒前
Maestro_S的应助被tang采纳,获得100
11秒前
细腻谷南完成签到,获得积分10
11秒前
完美世界的应助被zzz采纳,获得10
11秒前
11秒前
学霸颖发布了新的文献求助10
12秒前
13秒前
cora发布了新的文献求助10
13秒前
夜雨完成签到 ,获得积分10
13秒前
14秒前
荼蘼发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241